{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:05:19Z","timestamp":1789830319526,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"DOI":"10.1007\/s00702-026-03291-0","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:51:28Z","timestamp":1789829488000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Health economics of Parkinson\u2019s disease prevention: why early detection matters in low- and middle-income countries"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5317-7369","authenticated-orcid":false,"given":"Roland Dominic G.","family":"Jamora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mykha Marie B.","family":"Tabuzo-Acuin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norlinah Mohamed","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6758-0981","authenticated-orcid":false,"given":"Yoshio","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"issue":"12","key":"3291_CR1","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/mds.23878","volume":"26","author":"J Bach","year":"2011","unstructured":"Bach J, Ziegler U, Deuschl G, Dodel R, Doblhammer-Reiter G (2011) Projected numbers of people with movement disorders in the years 2030 and 2050. Mov Disord 26(12):2286\u20132290. https:\/\/doi.org\/10.1002\/mds.23878","journal-title":"Mov Disord"},{"issue":"11","key":"3291_CR2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1586\/14737175.2015.1088783","volume":"15","author":"R Bhidayasiri","year":"2015","unstructured":"Bhidayasiri R, Hattori N, Jeon BS, Chen RS, Lee MK, Bajwa J, Mok VC, Zhang B, Syamsudin T, Tan LC, Jamora RD, Pisarnpong A, Poewe W (2015) Asian perspectives on the recognition and management of levodopa \u2018wearing-off\u2019 in Parkinson\u2019s disease. Expert Rev Neurother 15(11):1285\u20131297. https:\/\/doi.org\/10.1586\/14737175.2015.1088783","journal-title":"Expert Rev Neurother"},{"issue":"7","key":"3291_CR3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00702-023-02662-1","volume":"130","author":"R Bhidayasiri","year":"2023","unstructured":"Bhidayasiri R, Sringean J, Van Le T, Lim TT, Navuth C, Phoumindr A, Aye WM, Phumphid S, Vorachit S, Veasna K, Ibrahim NM, Thit WM, Rosales RL, Le M, Tran NT (2023) Movement disorders in Indochina: resource challenges and future solutions. J Neural Trans (Vienna) 130(7):875\u2013889. https:\/\/doi.org\/10.1007\/s00702-023-02662-1","journal-title":"J Neural Trans (Vienna)"},{"issue":"44","key":"3291_CR4","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3238\/arztebl.2019.0747","volume":"116","author":"R Buchert","year":"2019","unstructured":"Buchert R, Buhmann C, Apostolova I, Meyer PT, Gallinat J (2019) Nuclear imaging in the diagnosis of clinically uncertain parkinsonian syndromes. Dtsch Arztebl Int 116(44):747\u2013754. https:\/\/doi.org\/10.3238\/arztebl.2019.0747","journal-title":"Dtsch Arztebl Int"},{"key":"3291_CR5","doi-asserted-by":"publisher","first-page":"973310","DOI":"10.3389\/fnagi.2022.973310","volume":"14","author":"F Chen","year":"2022","unstructured":"Chen F, Chen S, Si A, Luo Y, Hu W, Zhang Y, Ma J (2022) The long-term trend of Parkinson\u2019s disease incidence and mortality in China and a Bayesian projection from 2020 to 2030. Front Aging Neurosci 14:973310. https:\/\/doi.org\/10.3389\/fnagi.2022.973310","journal-title":"Front Aging Neurosci"},{"key":"3291_CR6","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/mdc3.14192","volume":"11","author":"N Fothergill-Misbah","year":"2024","unstructured":"Fothergill-Misbah N, Hooker J, Kwasa J, Walker R (2024) Access to medicines for Parkinson\u2019s disease in Kenya: a qualitative exploration. Mov Disord Clin Pract 11:1373\u20131378. https:\/\/doi.org\/10.1002\/mdc3.14192","journal-title":"Mov Disord Clin Pract"},{"issue":"8","key":"3291_CR7","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/mds.27372","volume":"33","author":"SH Fox","year":"2018","unstructured":"Fox SH, Katzenschlager R, Lim S, Barton B, de Bie RM, Seppi K, Coelho M, Sampaio C (2018) International Parkinson and Movement Disorder Society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson\u2019s disease. Mov Disord 33(8):1248\u20131266. https:\/\/doi.org\/10.1002\/mds.27372","journal-title":"Mov Disord"},{"issue":"7526","key":"3291_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nj7526-299a","volume":"515","author":"K Gammon","year":"2014","unstructured":"Gammon K (2014) Neurodegenerative disease: brain windfall. Nature 515(7526):299\u2013300. https:\/\/doi.org\/10.1038\/nj7526-299a","journal-title":"Nature"},{"issue":"3","key":"3291_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3233\/jpd-213006","volume":"12","author":"ZH Goh","year":"2022","unstructured":"Goh ZH, Cheong JL, Marras C, Tanner CM, Kasten M, Korczyn AD, Chahine L, Lo R, Noyce AJ (2022) Surveying global availability of Parkinson\u2019s disease treatment. J Parkinsons Dis 12(3):1023\u20131034. https:\/\/doi.org\/10.3233\/jpd-213006","journal-title":"J Parkinsons Dis"},{"key":"3291_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.600878","volume":"9","author":"N Gyawali","year":"2021","unstructured":"Gyawali N, Al-Amin HM (2021) Living and dying with COVID-19 in South Asian low- and middle-income countries. Front Public Health 9:600878. https:\/\/doi.org\/10.3389\/fpubh.2021.600878","journal-title":"Front Public Health"},{"issue":"S1","key":"3291_CR11","doi-asserted-by":"publisher","first-page":"S241","DOI":"10.3233\/JPD-230213","volume":"14","author":"D Hartmann-Nardin","year":"2024","unstructured":"Hartmann-Nardin D, Stock S, Kalbe E, Folkerts AK (2024) Cost-effectiveness analyses of non-pharmacological and non-surgical interventions in idiopathic Parkinson\u2019s disease: a systematic review. J Parkinsons Dis 14(S1):S241\u2013S252. https:\/\/doi.org\/10.3233\/JPD-230213","journal-title":"J Parkinsons Dis"},{"issue":"9","key":"3291_CR12","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2165\/11316770-000000000-00000","volume":"26","author":"A Haycox","year":"2009","unstructured":"Haycox A, Armand C, Murteira S, Cochran J, Fran\u00e7ois C (2009) Cost effectiveness of rasagiline and pramipexole as treatment strategies in early Parkinson\u2019s disease in the UK setting: an economic Markov model evaluation. Drugs Aging 26(9):791\u2013801. https:\/\/doi.org\/10.2165\/11316770-000000000-00000","journal-title":"Drugs Aging"},{"issue":"5","key":"3291_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2165\/00019053-199814050-00006","volume":"14","author":"TJ Hoerger","year":"1998","unstructured":"Hoerger TJ, Bala MV, Rowland C, Greer M, Chrischilles EA, Holloway RG (1998) Cost effectiveness of pramipexole in Parkinson\u2019s disease in the US. PharmacoEconomics 14(5):541\u2013557. https:\/\/doi.org\/10.2165\/00019053-199814050-00006","journal-title":"PharmacoEconomics"},{"issue":"2","key":"3291_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s42379-025-00198-3","volume":"9","author":"MJ Hwang","year":"2025","unstructured":"Hwang MJ (2025) Demographic change in East Asia: cultural legacies, contemporary challenges, and strategic responses. China Popul Dev Stud 9(2):142\u2013150. https:\/\/doi.org\/10.1007\/s42379-025-00198-3","journal-title":"China Popul Dev Stud"},{"issue":"1","key":"3291_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-68197-z","volume":"17","author":"D Ikhile","year":"2026","unstructured":"Ikhile D, Highton P, Gillies C, Abdala R, Ardavani A, Arora M, Banstola A, Brahmbhatt A, Cassambai S, Funnell MP, Goenka S, Jeffers S, Kondal D, Mohan S, Mulakalapalli P, Oli N, Peace A, Singh K, Vaidya A, Khunti K (2026) Quality of life and multiple long-term conditions in Southeast Asia: a systematic review and meta-analysis. Nat Commun 17(1):1461. https:\/\/doi.org\/10.1038\/s41467-025-68197-z","journal-title":"Nat Commun"},{"issue":"2","key":"3291_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10654-023-01094-1","volume":"39","author":"MA Ikram","year":"2024","unstructured":"Ikram MA, Kieboom BCT, Brouwer WP, Brusselle G, Chaker L, Ghanbari M, Goedegebure A, Ikram MK, Kavousi M, Knegt R, Luik AI, Meurs J, Pardo LM, Rivadeneira F, Rooij FJ, Vernooij MW, Voortman T, Terzikhan N (2024) The Rotterdam Study. Design update and major findings between 2020 and 2024. Eur J Epidemiol 39(2):183\u2013206. https:\/\/doi.org\/10.1007\/s10654-023-01094-1","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"3291_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2217\/nmt-2017-0014","volume":"7","author":"RD Jamora","year":"2017","unstructured":"Jamora RD, Miyasaki JM (2017) Treatment gaps in Parkinson\u2019s disease care in the Philippines. Neurodegener Dis Manag 7(4):245\u2013251. https:\/\/doi.org\/10.2217\/nmt-2017-0014","journal-title":"Neurodegener Dis Manag"},{"key":"3291_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1091533","volume":"11","author":"A Jayaraman","year":"2023","unstructured":"Jayaraman A, Fernandez A (2023) Role of civil society in health care: mechanisms for realizing universal health coverage in vulnerable communities of India. Front Public Health 11:1091533. https:\/\/doi.org\/10.3389\/fpubh.2023.1091533","journal-title":"Front Public Health"},{"issue":"7","key":"3291_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0288269","volume":"18","author":"AH Kaiser","year":"2023","unstructured":"Kaiser AH, Rotigliano N, Flessa S, Ekman B, Sundewall J (2023) Extending universal health coverage to informal workers: a systematic review of health financing schemes in low- and middle-income countries in Southeast Asia. PLoS One 18(7):e0288269. https:\/\/doi.org\/10.1371\/journal.pone.0288269","journal-title":"PLoS One"},{"issue":"5","key":"3291_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3961\/jpmph.22.195","volume":"55","author":"Y Kim","year":"2022","unstructured":"Kim Y, Kim Y, Lee HJ, Lee S, Park SY, Oh SH, Jang S, Lee T, Ahn J, Shin S (2022) The primary process and key concepts of economic evaluation in healthcare. J Prev Med Public Health 55(5):415\u2013423. https:\/\/doi.org\/10.3961\/jpmph.22.195","journal-title":"J Prev Med Public Health"},{"issue":"4","key":"3291_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-095610","volume":"15","author":"M Li","year":"2025","unstructured":"Li M, Ye X, Huang Z, Ye L, Chen C (2025) Global burden of Parkinson\u2019s disease from 1990 to 2021: a population-based study. BMJ Open 15(4):e095610. https:\/\/doi.org\/10.1136\/bmjopen-2024-095610","journal-title":"BMJ Open"},{"issue":"3","key":"3291_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/mds.23462","volume":"26","author":"P Martinez-Martin","year":"2011","unstructured":"Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR, NMSS Validation Group (2011) The impact of non-motor symptoms on health-related quality of life of patients with Parkinson\u2019s disease. Mov Disord 26(3):399\u2013406. https:\/\/doi.org\/10.1002\/mds.23462","journal-title":"Mov Disord"},{"issue":"6","key":"3291_CR23","doi-asserted-by":"publisher","first-page":"a008870","DOI":"10.1101\/cshperspect.a008879","volume":"2","author":"J Massano","year":"2012","unstructured":"Massano J, Bhatia KP (2012) Clinical approach to Parkinson\u2019s disease: features, diagnosis, and principles of management. Cold Spring Harb Perspect Med 2(6):a008870. https:\/\/doi.org\/10.1101\/cshperspect.a008879","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"3291_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/mdc3.70447","volume":"13","author":"N Mohamed Ibrahim","year":"2025","unstructured":"Mohamed Ibrahim N, Phuenpathom W, Jagota P, Bhidayasiri R, Pal PK, Lin C, Kukkle PL, Hatano T, Lim S, Myrzayev Z, Shang H, Ong JN, Rosales RL, Youn J, Aldaajani Z, Mittal SO, Nawi AM, Ugawa Y (2025) Practices, resources and challenges in Parkinson\u2019s disease management in Asia: movement disorders in Asia study group report. Mov Disord Clin Pract 13(2):379\u2013392. https:\/\/doi.org\/10.1002\/mdc3.70447","journal-title":"Mov Disord Clin Pract"},{"issue":"7 Suppl","key":"3291_CR25","first-page":"S183","volume":"18","author":"DL Murman","year":"2012","unstructured":"Murman DL (2012) Early treatment of Parkinson\u2019s disease: opportunities for managed care. Am J Manag Care 18(7 Suppl):S183\u2013S188","journal-title":"Am J Manag Care"},{"issue":"12","key":"3291_CR26","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2165\/00019053-200523120-00009","volume":"23","author":"K Noyes","year":"2005","unstructured":"Noyes K, Dick AW, Holloway RG, Parkinson Study Group (2005) Pramipexole and levodopa in early Parkinson\u2019s disease: dynamic changes in cost effectiveness. Pharmacoeconomics 23(12):1257\u20131270. https:\/\/doi.org\/10.2165\/00019053-200523120-00009","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"3291_CR27","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.27115","volume":"32","author":"JA Obeso","year":"2017","unstructured":"Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ (2017) Past, present, and future of Parkinson\u2019s disease: a special essay on the 200th Anniversary of the Shaking Palsy. Mov Disord 32(9):1264\u20131310. https:\/\/doi.org\/10.1002\/mds.27115","journal-title":"Mov Disord"},{"key":"3291_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-026-03256-3","author":"PH Pelicioni","year":"2026","unstructured":"Pelicioni PH, Waller S, Chan L, Krishnan AV, Lord SR, Brodie MA (2026) Real-world gait changes preceding Parkinson\u2019s disease diagnosis in a population-scale UK biobank cohort. J Neural Transm. https:\/\/doi.org\/10.1007\/s00702-026-03256-3","journal-title":"J Neural Transm"},{"key":"3291_CR29","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"11","key":"3291_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2025-020052","volume":"10","author":"MM Rahman","year":"2025","unstructured":"Rahman MM, Ii M, Lohan M, Kassai R, Awan R, Pempa P, Sato M (2025) Progress towards universal health coverage in South Asia, 2000\u20132030: an examination of the twin elements of primary healthcare provision and financial protection. BMJ Glob Health 10(11):e020052. https:\/\/doi.org\/10.1136\/bmjgh-2025-020052","journal-title":"BMJ Glob Health"},{"issue":"Suppl 1","key":"3291_CR31","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.1016\/S1353-8020(11)70062-1","volume":"18","author":"GW Ross","year":"2012","unstructured":"Ross GW, Abbott RD, Petrovitch H, Tanner CM, White LR (2012) Pre-motor features of Parkinson\u2019s disease: the Honolulu-Asia aging study experience. Parkinsonism Relat Disord 18(Suppl 1):S199\u2013S202. https:\/\/doi.org\/10.1016\/S1353-8020(11)70062-1","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"3291_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/mds.27063","volume":"33","author":"A Rossi","year":"2017","unstructured":"Rossi A, Berger K, Chen H, Leslie D, Mailman RB, Huang X (2017) Projection of the prevalence of Parkinson\u2019s disease in the coming decades: revisited. Mov Disord 33(1):156\u2013159. https:\/\/doi.org\/10.1002\/mds.27063","journal-title":"Mov Disord"},{"issue":"1","key":"3291_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.parkreldis.2005.06.011","volume":"12","author":"A Schrag","year":"2006","unstructured":"Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M (2006) Caregiver-burden in Parkinson\u2019s disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat Disord 12(1):35\u201341. https:\/\/doi.org\/10.1016\/j.parkreldis.2005.06.011","journal-title":"Parkinsonism Relat Disord"},{"key":"3291_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.irmvd.2025.09.007","volume-title":"International Review of Movement Disorders","author":"J Sringean","year":"2025","unstructured":"Sringean J, Panyakaew P, Phokaewvarangkul O, Jagota P, Phoumindr A, Phuenpathom W, Maytharakcheep S, Lim TT, Tran TN, Vorachit S, Aye WM, Bhidayasiri R (2025) Bridging the training gap in movement disorders: a regional curriculum framework. In: Bhidayasiri R, Falup-Pecurariu (eds) International Review of Movement Disorders, vol 10, 1st edn. Academic, New York, pp 1\u201331. https:\/\/doi.org\/10.1016\/bs.irmvd.2025.09.007","edition":"1"},{"key":"3291_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su D, Cui Y, He C, Yin P, Bai R, Zhu J, Lam JS, Zhang J, Yan R, Zheng X, Wu J, Zhao D, Wang A, Zhou M, Feng T (2025) Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ 388:e080952. https:\/\/doi.org\/10.1136\/bmj-2024-080952","journal-title":"BMJ"},{"issue":"3","key":"3291_CR36","first-page":"231","volume":"18","author":"LC Tan","year":"2013","unstructured":"Tan LC (2013) Epidemiology of Parkinson\u2019s disease. Neurol Asia 18(3):231\u2013238","journal-title":"Neurol Asia"},{"key":"3291_CR37","unstructured":"Tinelli M, Kanavos P, Grimaccia F (2016) The value of early diagnosis and treatment in Parkinson\u2019s disease: a literature review of the potential clinical and socioeconomic impact of targeting unmet needs in Parkinson\u2019s disease. LSE Consulting.\u00a0https:\/\/www.lse.ac.uk\/business\/consulting\/reports\/the-value-of-early-diagnosis. Accessed 10 May 2026"},{"issue":"2","key":"3291_CR38","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.euroneuro.2010.08.002","volume":"21","author":"S von Campenhausen","year":"2011","unstructured":"von Campenhausen S, Winter Y, Rodrigues e Silva A, Sampaio C, Ruzicka E, Barone P, Poewe W, Guekht A, Mateus C, Pfeiffer KP, Berger K, Skoupa J, B\u00f6tzel K, Geiger-Gritsch S, Siebert U, Balzer-Geldsetzer M, Oertel WH, Dodel R, Reese JP (2011) Costs of illness and care in Parkinson\u2019s disease: an evaluation in six countries. Eur Neuropsychopharmacol 21(2):180\u2013191. https:\/\/doi.org\/10.1016\/j.euroneuro.2010.08.002","journal-title":"Eur Neuropsychopharmacol"},{"issue":"9","key":"3291_CR39","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/mds.27447","volume":"33","author":"M Wanneveich","year":"2018","unstructured":"Wanneveich M, Moisan F, Jacqmin-Gadda H, Elbaz A, Joly P (2018) Projections of prevalence, lifetime risk, and life expectancy of Parkinson\u2019s disease (2010\u20102030) in France. Mov Disord 33(9):1449\u20131455. https:\/\/doi.org\/10.1002\/mds.27447","journal-title":"Mov Disord"},{"issue":"10","key":"3291_CR40","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00702-024-02807-w","volume":"131","author":"D Weise","year":"2024","unstructured":"Weise D, Claus I, Dresel C, Kalbe E, Liepelt-Scarfone I, Lorenzl S, Redecker C, Urban P (2024) Multidisciplinary care in Parkinson\u2019s disease. J Neural Transm (Vienna) 131(10):1217\u20131227. https:\/\/doi.org\/10.1007\/s00702-024-02807-w","journal-title":"J Neural Transm (Vienna)"},{"issue":"11","key":"3291_CR41","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1002\/mds.29995","volume":"39","author":"A Wijers","year":"2024","unstructured":"Wijers A, Ravi A, Evers SMAA, Tissingh G, van Mastrigt GA (2024) Systematic review of the cost of illness of Parkinson\u2019s disease from a societal perspective. Mov Disord 39(11):1938\u20131951. https:\/\/doi.org\/10.1002\/mds.29995","journal-title":"Mov Disord"},{"key":"3291_CR42","unstructured":"World Bank Country and lending groups (2026) World Bank Country and Lending Groups \u2013 World Bank Data Help Desk. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups. Accessed 10 May 2026"},{"key":"3291_CR43","unstructured":"World Health Organization (2022) Parkinson disease: a public health approach. Technical brief. https:\/\/www.who.int\/publications\/i\/item\/9789240050983. Accessed 15 Aug 2026"},{"key":"3291_CR44","unstructured":"World Health Organization (2026) Health financing. World Health Organization. https:\/\/www.who.int\/health-topics\/health-financing#tab=tab_1. Accessed 10 May 2026"},{"issue":"5","key":"3291_CR45","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1159\/000542606","volume":"59","author":"Q Yang","year":"2024","unstructured":"Yang Q, Chang X, Li S, Li X, Kang C, Yuan W (2024) Disease burden of Parkinson\u2019s disease in Asia and its 34 countries and territories from 1990 to 2021: findings from the global burden of disease study 2021. Neuroepidemiology 59(5):525\u2013557. https:\/\/doi.org\/10.1159\/000542606","journal-title":"Neuroepidemiology"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03291-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-026-03291-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03291-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:51:32Z","timestamp":1789829492000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-026-03291-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":45,"alternative-id":["3291"],"URL":"https:\/\/doi.org\/10.1007\/s00702-026-03291-0","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"assertion":[{"value":"11 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}